These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6454820)
1. Injectable contraception. Edwards JR Med J Aust; 1981 Jun; 1(12):651-2. PubMed ID: 6454820 [TBL] [Abstract][Full Text] [Related]
2. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
3. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Polaneczky M; Guarnaccia M; Alon J; Wiley J Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283 [TBL] [Abstract][Full Text] [Related]
4. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Kaunitz AM Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206 [TBL] [Abstract][Full Text] [Related]
5. Injectable contraception. Wilson E Practitioner; 1988 Jan; 232(1441):32-6. PubMed ID: 2975377 [TBL] [Abstract][Full Text] [Related]
6. Depo-Provera use in an Australian metropolitan practice. Fraser IS; Dennerstein GJ Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553 [TBL] [Abstract][Full Text] [Related]
7. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception. Nelson AL J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701 [TBL] [Abstract][Full Text] [Related]
9. Use of depot medroxyprogesterone acetate contraception in adolescents. Davis AJ J Reprod Med; 1996 May; 41(5 Suppl):407-13. PubMed ID: 8725703 [TBL] [Abstract][Full Text] [Related]
10. Statement on injectable contraception. International Planned Parenthood Federation IPPF IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511 [TBL] [Abstract][Full Text] [Related]
12. Medroxyprogesterone acetate as an injectable contraceptive. Heber KR Aust Fam Physician; 1988 Mar; 17(3):199-201, 204. PubMed ID: 2965570 [TBL] [Abstract][Full Text] [Related]
13. New aspects of injectable contraception. Phillips OP Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618 [TBL] [Abstract][Full Text] [Related]
14. Depot medroxyprogesterone acetate contraception in women with medical problems. Frederiksen MC J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of injectable contraceptive users in a low-income population in Texas. Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608 [TBL] [Abstract][Full Text] [Related]
16. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues? Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125 [TBL] [Abstract][Full Text] [Related]
17. Long-acting contraceptive options. Kaunitz AM Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701 [TBL] [Abstract][Full Text] [Related]
18. Current concepts regarding use of DMPA. Kaunitz AM J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407 [TBL] [Abstract][Full Text] [Related]
19. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705 [TBL] [Abstract][Full Text] [Related]
20. Use of depo-provera in teens. Khoiny FE J Pediatr Health Care; 1996; 10(5):195-201. PubMed ID: 8920351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]